View More View Less
  • 1 Microbiology Laboratory, Gaziantep Dr. Ersin Arslan Training and Research Hospital, Gaziantep, , Turkey
  • | 2 Service of Microbiology, Hospital Universitario Marqués de Valdecilla, Santander, , Spain
  • | 3 Clinical Microbiology Department, School of Medicine, Baskent University, Adana, , Turkey
  • | 4 Clinical Unit of Microbiology, Department of Microbiology, Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba, Córdoba, , Spain
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

Escherichia coli and Klebsiella pneumoniae are frequently found resistance to aminoglycosides in Turkey. The aim of this study was to investigate aminoglycoside resistance in clinical isolates of E. coli and K. pneumoniae from Turkey using both phenotypic and genotypic methods and screening for the prevalence of gene coding for common aminoglycoside-modifying enzymes (AMEs) and 16S rRNA methylase genes. A total of 88 consecutive, non-duplicated E. coli (n = 65) and K. pneumoniae (n = 23) isolates showing resistance or intermediate resistance to amikacin and/or gentamicin were collected between October 2013 and May 2015 from clinical samples received at Gaziantep Dr. Ersin Arslan Training and Research Hospital. Seventeen isolates were obtained from Syrian patients. Isolates resistant to any of the two aminoglycosides were tested by PCR for seven AME genes, and 22 isolates with amikacin MIC ≥16 mg/L were also tested for 16S rRNA methylase genes. In E. coli isolates, the most frequent genes were aac(6′)-Ib (50 strains; 76.9%) and aac(3)-IIa (40 strains; 70.7%), followed by aph(3′)-Ia (5 strains; 7.6%) and ant(2″)-Ia (2 strains; 3.1%). Among the 23 resistant K. pneumoniae isolates, the most prevalent gene was aac(3′)-IIa (87.0%) followed by aac(6′)-Ib (73.9%) and aph(3′)-Ia (8.6%). The rmtC gene was detected in one K. pneumoniae isolate. Resistance to aminoglycosides in clinical isolates of E. coli and K. pneumoniae from our center is predominantly caused by AAC(6′)-Ib and AAC(3)-II enzymes, while the occurrence of 16S rRNA methylases is so far limited.

  • 1.

    Miró, E., Grünbaum, F., Gómez, L., Rivera, A., Mirelis, B., Coll, P., Navarro, F.: Characterization of aminoglycoside-modifying enzymes in Enterobacteriaceae clinical strains and characterization of the plasmids implicated in their diffusion. Microb Drug Resist 19, 9499 (2013).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2.

    Fernandez-Martınez, M., Miro, E., Ortega, A., Bou, G., Gonzalez-Lopez, J. J., Oliver, A., Pascual, A., Cercenado, E., Oteo, J., Martınez-Martınez, L., Navarro, F.: Spanish network for the research in infectious diseases (REIPI): Molecular identification of aminoglycoside modifying enzymes in clinical isolates of Escherichia coli resistant to amoxicillin/clavulanic acid isolated in Spain. Int J Antimicrob Agents 46, 157163 (2015).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Ramirez, M. S., Tolmasky, M. E.: Aminoglycoside modifying enzymes. Drug Resist Update 13, 151171 (2010).

  • 5.

    Wachino, J., Arakawa, Y.: Exogenously acquired 16S rRNA methyltransferases found in aminoglycoside-resistant pathogenic Gram-negative bacteria: An update. Drug Resist Updat 15, 133148 (2012).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6.

    Haldorsen, B. C., Simonsen, G. S., Sundsfjord, A., Samuelsen, O., Norwegian Study Group on Aminoglycoside Resistance: Increased prevalence of aminoglycoside resistance in clinical isolates of Escherichia coli and Klebsiella spp. in Norway is associated with the acquisition of AAC(3)-II and AAC(6¢)-Ib. Diagn Microbiol Infect Dis 78, 6669 (2014).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7.

    Clinical and Laboratory Standards Institute: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard, 9th Edition. . CLSI, Wayne, PA, 2012.

    • Search Google Scholar
    • Export Citation
  • 8.

    Park, C. H., Robicsek, A., Jacoby, G. A., Sahm, D., Hooper, D. C.: Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 50, 39533955 (2006).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Galimand, M., Courvalin, P., Lambert, T.: Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation. Antimicrob Agents Chemother 47, 25652571 (2003).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    Fritsche, T. R., Castanheira, M., Miller, G. H., Jones, R. N., Armstrong, E. S.: Detection of methyltransferases conferring high-level resistance to aminoglycosides in Enterobacteriaceae from Europe, North America, and Latin America. Antimicrob Agents Chemother 52, 18431845 (2008).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11.

    Doi, Y., Arakawa, Y.: 16S ribosomal RNA methylation: Emerging resistance mechanism against aminoglycosides. Clin Infect Dis 45, 8894 (2007).

  • 12.

    Castanheira, M., Fritsche, T. R., Sader, H. S., Jones, R. N.: RmtD 16S RNA methylase in epidemiologically unrelated SPM-1-producing Pseudomonas aeruginosa isolates from Brazil. Antimicrob Agents Chemother 52, 15871588 (2008).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Fernandez-Martinez, M., Ruiz del Castillo, B., Lecea-Cuello, M. J., Rodriguez-Bano, J., Pascual, A., Martinez-Martinez, L., Spanish Network for the Research in Infectious Diseases (REIPI), The Spanish Group for Nosocomial Infections (GEIH): Prevalence of aminoglycoside-modifying enzymes in Escherichia coli and Klebsiella pneumoniae producing extended spectrum β-lactamases collected in two multicenter studies in Spain. Microb Drug Resist 24, 367376 (2018).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14.

    Over, U., Gür, D., Unal, S., Miller, G. H., Aminoglycoside Resistance Study Group: The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey. Clin Microbiol Infect 7, 470478 (2001).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15.

    Bercot, B., Poirel, L., Ozdamar, M., Hakko, E., Turkoglu, S., Nordmann, P.: Low prevalence of 16S methylases among extended-spectrum β-lactamase-producing Enterobacteriaceae from a Turkish hospital. J Antimicrob Chemother 65, 797798 (2010).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 16.

    Yokoyama, K., Doi, Y., Yamane, K., Kurokawa, H., Shibata, N., Shibayama, K., Yagi, T., Kato, H., Arakawa, Y.: Acquisition of 16S rRNA methylase gene in Pseudomonas aeruginosa. Lancet 362, 18881893 (2003).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 17.

    Guven Gokmen, T., Nagiyev, T., Meral, M., Onlen, C., Heydari, F., Koksal, F.: NDM-1 and rmtC-producing Klebsiella pneumoniae isolates in Turkey. Jundishapur J Microbiol 9, e33990 (2016).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18.

    Ermertcan, S., Yilmaz, F. F., Tasli, H., Yurtman, A. N., Aydemir, S. S., Hosgor Limoncu, M.: Investigation of plasmid mediated methylase genes in aminoglycoside resistant Gram negative bacteria. Türk Mikrobiyol Cem Derg 43, 1216 (2013).

    • Search Google Scholar
    • Export Citation

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
submission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 652 EUR / 812 USD
Subscription fee 2022 Online subsscription: 662 EUR / 832 USD
Print + online subscription: 740 EUR / 930 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jun 2021 25 0 0
Jul 2021 14 0 0
Aug 2021 18 0 0
Sep 2021 18 0 0
Oct 2021 41 0 0
Nov 2021 12 2 2
Dec 2021 3 0 0